Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission

Clinical Microbiology and Infection

Volumn 16, Issue 7, 2010, Pages 902-908

  Nseir, S ^a,b   Grailles, G ^a   Soury Lavergne, A ^a   Minacori, F ^a   Alves, I ^a   Durocher, A ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Antibiotic treatment; Colonization; De escalation; Guidelines; Multidrug resistant bacteria; Pneumonia

Indexed keywords

CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM;

ACCURACY; ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NOSE SMEAR; NURSING HOME PATIENT; OBSERVATIONAL STUDY; PNEUMONIA; PRACTICE GUIDELINE; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; STENOTROPHOMONAS MALTOPHILIA; THROAT CULTURE; UNITED STATES;

ACINETOBACTER BAUMANNII; BACILLI (CLASS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

EID: 77954649852     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03027.x     Document Type: Article

References (36)

1. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med 2009, 360:439-443.
2. Kollef MH, Shorr A, Tabak YP. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005, 128:3854-3862.
3. Shorr AF, Tabak YP, Killian AD. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large US database. Crit Care Med 2006, 34:2588-2595.
4. Nseir S, Di Pompeo C, Cavestri B. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: prevalence, risk factors, and outcome. Crit Care Med 2006, 34:2959-2966.
5. Niederman MS. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Clin Infect Dis 2006, 42(suppl 2):S72-S81.
6. Mueller EW, Hanes SD, Croce MA. Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients. J Trauma 2005, 58:94-101.
7. Nseir S, Deplanque X, Di Pompeo C. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study. J Infect 2008, 56:319-325.
8. Ibrahim EH, Sherman G, Ward S. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
9. Teixeira PJ, Seligman R, Hertz FT. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes. J Hosp Infect 2007, 65:361-367.
10. Niederman MS, Craven DE. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
11. Niederman MS, Mandell LA, Anzueto A. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001, 163:1730-1754.
12. Garner JS, Jarvis WR, Emori TG. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
13. Niederman MS. The importance of de-escalating antimicrobial therapy in patients with ventilator-associated pneumonia. Semin Respir Crit Care Med 2006, 27:45-50.
14. Kreger BE, Craven DE, Carling PC. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 1980, 68:332-343.
15. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946.
16. Nseir S, Di Pompeo C, Diarra M. Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria: a case-control study. Crit Care Med 2007, 35:1318-1323.
17. Soo Hoo GW, Wen YE, Nguyen TV. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 2005, 128:2778-2787.
18. Nachtigall I, Tamarkin A, Tafelski S. Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patients. Crit Care Med 2009, 37:159-166.
19. Frei CR, Restrepo MI, Mortensen EM. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 2006, 119:865-871.
20. Shorr AF, Bodi M, Rodriguez A. Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia. Chest 2006, 130:93-100.
21. Rello J, Vidaur L, Sandiumenge A. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004, 32:2183-2190.
22. Aarts MA, Brun-Buisson C, Cook DJ. Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome? Intensive Care Med 2007, 33:1369-1378.
23. Kollef MH, Morrow LE, Niederman MS. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006, 129:1210-1218.
24. Micek ST, Ward S, Fraser VJ. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004, 125:1791-1799.
25. Ibrahim EH, Ward S, Sherman G. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001, 29:1109-1115.
26. Singh N, Rogers P, Atwood CW. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162:505-511.
27. Joffe AR, Muscedere J, Marshall JC. The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multicenter observational study. J Crit Care 2008, 23:82-90.
28. Nseir S, Di Pompeo C, Soubrier S. First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 2005, 33:283-289.
29. Nseir S, Di Pompeo C, Brisson H. Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome. Crit Care 2006, 10:R143.
30. Warren DK, Guth RM, Coopersmith CM. Impact of a methicillin-resistant Staphylococcus aureus active surveillance program on contact precaution utilization in a surgical intensive care unit. Crit Care Med 2007, 35:430-434.
31. Lucet JC, Chevret S, Durand-Zaleski I. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003, 163:181-188.
32. Harbarth S, Fankhauser C, Schrenzel J. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149-1157.
33. Harris AD, McGregor JC, Johnson JA. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007, 13:1144-1149.
34. Martinez JA, Delgado E, Marti S. Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients. Intensive Care Med 2009, 35:439-47.
35. Tacconelli E, De Angelis G, Cataldo MA. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008, 61:26-38.
36. Chastre J. Evolving problems with resistant pathogens. Clin Microbiol Infect 2008, 14(suppl 3):3-14.